Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 July 2025 | Story Precious Shamase | Photo Supplied
SACE
Signing of the MoU between SACE and the UFS, which took place at the SACE Head Office in Centurion, Pretoria. Pictured are Prof Loyiso Jita, Dean: Education, and Ella Mokgalane, SACE CEO.

The University of the Free State (UFS) has taken a groundbreaking step in teacher education, becoming the first university in South Africa to facilitate the provisional registration of its student teachers with the South African Council for Educators (SACE) before they embark on their crucial Work Integrated Learning (WIL) phase. This landmark achievement follows the recent signing of a Memorandum of Understanding (MOU) between the UFS and SACE, solidifying a collaborative commitment to regulatory compliance and professional development for future educators.

 

Direct SACE support for student teachers

In June 2025, SACE representatives, led by Harold Tlomatsana, the Provincial Head for SACE in the Free State Province, conducted a dedicated support visit to the Qwaqwa Campus. The purpose of their visit was to directly assist student teachers in completing their online provisional registration applications. The university's Faculty of Education, through its Teaching Practice Directorate, played a pivotal role in this initiative, graciously providing access to its computer laboratories to ensure a seamless and efficient registration process for all students.

This proactive approach ensures that all UFS student teachers are officially registered with SACE, a vital prerequisite for their upcoming July practice teaching component. It is important to note that this provisional registration is distinct from employment-related functions; rather, it stresses the commitment of both institutions to ensure that all aspiring educators are properly recognised and compliant with national standards before gaining practical experience in classrooms.

The signing of the MOU by Prof Loyiso Jita, Dean of the Faculty of Education, alongside SACE representatives, marks a significant milestone. It not only formalises the partnership but also highlights the UFS' dedication to upholding the highest professional standards in teacher training.

 

A national precedent set

Prof Thuthukile Jita, Director of the Teaching Practice Directorate (TPD), expressed her enthusiasm for this pioneering collaboration. "This initiative is a testament to the hard work and foresight of our team in the Faculty of Education and the TPD office," said Prof Jita. "By partnering with SACE, we are not only streamlining a crucial administrative process for our students but also setting a national precedent for how universities can ensure that their future teachers are fully prepared and compliant with professional regulations from the very outset of their practical training."

The positive impact of this initiative will resonate across all UFS campuses – Bloemfontein, South, and Qwaqwa – stressing the comprehensive reach of the TPD office under Prof Jita's leadership.

 

Formalising a key partnership: a culmination of continued collaboration

The recent signing of the MOU formal agreement representing not only a new beginning, but rather a culmination of robust, continued collaboration between the UFS and SACE. Both institutions have long shared a commitment to ensuring the highest professional standards for future educators. The MOU formalises and strengthens these existing ties, highlighting the UFS' dedication to upholding the highest professional standards in teacher training and streamlining critical processes for its students.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept